Results 151 to 160 of about 33,623 (258)

MANGO‐“Fruitcage”: A Conditional Photocage Utilizing a Fluorescence Light‐Up Aptamer

open access: yesAdvanced Optical Materials, Volume 14, Issue 29, 7 August 2026.
Fruitcaging ‐ a proof of concept study of a conditional photocage (Thiazol‐Orange) activated upon binding to the fluorescence light up aptamer (Mango). The prolongation of the excited state lifetime explains the redirection of the reactive pathway toward photocleavage and provides a sensitive spectroscopic readout.
Konstantinos Stamatakis   +6 more
wiley   +1 more source

Publisher Correction: State of the art: glioma-associated epilepsy-bridging tumor biology and epileptogenesis. [PDF]

open access: yesNeurol Res Pract
Divé I   +7 more
europepmc   +1 more source

Feasibility of Integrating a Standardized Psychosocial Follow‐Up After Childhood Cancer—An Interim Analysis of the LE‐Na Study

open access: yesCancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Background Many childhood and adolescent cancer survivors suffer from late effects that impair quality of life and life expectancy. However, only an estimated 5% of > 47,000 survivors in Germany receive adequate long‐term follow‐up (LTFU) care.
Madelaine Sleimann   +22 more
wiley   +1 more source

Correction: Discovery of fully synthetic FKBP12-mTOR molecular glues. [PDF]

open access: yesChem Sci
Deutscher RCE   +10 more
europepmc   +1 more source

Percutaneous Deployment of the Sinus‐SuperFlex‐DS Stent for Hybrid Stage I Palliation in Neonates Weighing ≤ 2.5 kg: A Multicenter Study

open access: yesCatheterization and Cardiovascular Interventions, Volume 108, Issue 2, Page 644-652, August 1, 2026.
ABSTRACT Background Hybrid stage I palliation (HS1P) has developed as an alternative to the Norwood stage I palliation for neonates with hypoplastic left heart and related left‐sided obstructive lesions. HS1P is currently used in various clinical settings, such as single ventricle palliation, bridge to decision, bridge to biventricular repair, or ...
Johanna Hummel   +8 more
wiley   +1 more source

Sustained Effectiveness of Lanadelumab in Preventing Hereditary Angioedema Attacks: The ENABLE Study

open access: yesClinical and Translational Allergy, Volume 16, Issue 8, August 2026.
ABSTRACT Background Lanadelumab has been approved for hereditary angioedema (HAE) long‐term prophylaxis since 2018. The Phase 4, prospective ENABLE Study (NCT04130191) evaluated the long‐term effectiveness and safety of lanadelumab in clinical practice across Europe and the Middle East.
Andrea Zanichelli   +15 more
wiley   +1 more source

Study Protocol: It is time to dig deeper: A cross-country implementation mapping study of the iFightDepression® (online self-management) tool. [PDF]

open access: yesPLoS One
Rotter T   +13 more
europepmc   +1 more source

Prediction of the individual risk for the development of brain metastases in patients with non‐oncogene‐addicted non‐small cell lung cancer: Real‐world data from the German prospective CRISP registry (AIO‐TRK‐0315)

open access: yesInternational Journal of Cancer, Volume 159, Issue 3, Page 739-749, 1 August 2026.
What's New? Estimating the risk of developing brain metastases may enable earlier diagnosis and treatment, potentially reducing morbidity and mortality. Using the prospective CRISP lung cancer registry, the authors developed and validated a point‐based classifier for the risk of developing first brain metastases in patients with advanced or metastatic ...
Fabian Acker   +207 more
wiley   +1 more source

Home - About - Disclaimer - Privacy